newdrugapprovals.org
Japanese filing for Amgen’s PCSK9 inhibitor Repatha
Amgen has filed its closely watched PCSK9 inhibitor Repatha (evolocumab) in Japan for the treatment of high cholesterol. Repatha is an investigational fully human monoclonal antibody that inhibits …